FINISHED DOSAGE FORMULATIONS
Drug : CETIRIZINE HYDROCHLORIDE ALLERGY
Dosage Form : CAPSULE; ORAL
Application Number : 205291
Country : US
Patented : No
DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN
Drug : IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 200888
Country : US
Patented : No
Drug : NIFEDIPINE
Dosage Form : CAPSULE; ORAL
Application Number : 72781
Country : US
Patented : No
Drug : METHOXSALEN
Dosage Form : CAPSULE; ORAL
Application Number : 202603
Country : US
Patented : No
Drug : IBUPROFEN
Dosage Form : CAPSULE; ORAL
Application Number : 206999
Country : US
Patented : No
Drug : CETIRIZINE HYDROCHLORIDE ALLERGY
Dosage Form : CAPSULE; ORAL
Application Number : 207235
Country : US
Patented : No
Drug : AMANTADINE HYDROCHLORIDE
Dosage Form : CAPSULE; ORAL
Application Number : 78720
Country : US
Patented : No
Drug : IBUPROFEN
Dosage Form : CAPSULE; ORAL
Application Number : 78682
Country : US
Patented : No
Drug : CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Dosage Form : CAPSULE; ORAL
Application Number : 22429
Country : US
Patented : No
Drug : CETIRIZINE HYDROCHLORIDE ALLERGY
Dosage Form : CAPSULE; ORAL
Application Number : 22429
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
14 Sep 2022
REF. STANDARDS & IMPURITIES
LOOKING FOR A SUPPLIER?